Overview

Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma

Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
This trial studies how well serial magnetic resonance (MR) imaging and MR spectroscopic imaging work in characterizing lower grade glioma. Diagnostic procedures, such as MR imaging and MR spectroscopic imaging, may detect serial changes in lower grade glioma. This study may help researchers learn more about practical ways of evaluating and standardizing treatment in patients with brain tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Susan Chang
Collaborators:
GE Healthcare
Phillips-Medisize
Sigma-Aldrich